Table 1.
Baseline characteristics of patients who did (cases) and did not (controls) experience cardiovascular events during follow-up.
Table 2.
Absolute levels of 31 plasma amino acids in patients who did (cases) and did not (controls) experience cardiovascular events during follow-up.
Table 3.
Areas under the receiver-operating characteristic curves distinguishing patients who did (cases) and did not (controls) experience cardiovascular events during follow-up.
Table 4.
Hazard ratios for the cardiovascular composite endpoint.
Table 5.
Crude and multivariate-adjusted hazard ratios for the cardiovascular composite endpoint in patient subgroups stratified according to urinary albumin excretion rate and the CVD-AI.
Figure 1.
Results of area under the curve of receiver-operator characteristics curve analysis for both CVD-AI and urinary album excretion rate to distinguish cases from controls in all subjects and those with/without albuminuria.